Quick Answer
Adaptive Biotechnologies Corp reported Stockholders Equity of $218.79 million for fiscal year 2025.
Adaptive Biotechnologies Corp Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $218.79M | +7.9% |
| 2024 | $202.71M | -34.3% |
| 2023 | $308.40M | -33.6% |
| 2022 | $464.17M | -23.2% |
| 2021 | $603.99M | -18.7% |
| 2020 | $743.27M | +30.2% |
| 2019 | $571.04M | +321.2% |
| 2018 | -$258.11M | -14.9% |
| 2017 | -$224.62M | -18.4% |
| 2016 | -$189.73M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $204.44M | -8.6% | +13.8% |
| June 30, 2025 | $179.72M | -25.6% | -5.6% |
| March 31, 2025 | $190.42M | -30.7% | -6.1% |
| December 31, 2024 | $202.71M | -34.3% | -9.4% |
| September 30, 2024 | $223.77M | -38.1% | -7.4% |
| June 30, 2024 | $241.60M | -39.0% | -12.1% |
| March 31, 2024 | $274.91M | -35.2% | -10.9% |
| December 31, 2023 | $308.40M | -33.6% | -14.7% |
- Adaptive Biotechnologies Corp showed an increase of +7.9% in Stockholders Equity compared to the prior fiscal year.
- Over the 2016–2025 period, Adaptive Biotechnologies Corp’s stockholders equity has grown by 215.3% (from -$189.73 million to $218.79 million).
- The most recent figure is from Adaptive Biotechnologies Corp’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: